This re-designed spECTrum 4000Q is more economical, light-weight and portable than the 5000. The 4000Q model offers ﬂexibility with four parameter sets of Pulse Width, Frequency, Duration and Current. The treatment dosage is set using the four knobs beneath the LCD touch screen so that the user can easily see and quickly choose the best treatment option to maximize efﬁcacy and reduce side effects for the patient. The spECTrum ULTRABRIEF® (0.3 ms) pulse width settings and titration tables are included with all MECTA devices.
As the ECT section of the 5000 devices, it offers cost effectiveness without physiological monitoring, but still ensures that the clinician has all of the technology, safety and effectiveness of the 5000 spECTrum.
1.Where maximum ﬂexibility to select treatment parameters is desired.
2. Where alternative monitoring is available.
3. When a high degree of portability is required.
4. When cast-effectiveness is a priority.
spECTrum ULTRABRIEF® (0.3 ms) with up to sixteen therapeutic treatment parameters.
Six tactile membrane switches with only one selection menu.
Robust handle, small footprint and lightweight case.
Extensive regulatory agency approvals worldwide U.S. (UL); Canada (CSA, Health Canada 8 Approvals, #1537, #62573, #62576); European Union, TUV (EN ISO 13485:2012, EN ISO 13485:2012/AC:2002; CMDCAS ISO 13485:2003; EC 93/42/EEC Annex II, excluding Section 4); Korea (KFDA); China (SFDA); Indonesia (MOH); Australia (TGA); New Zealand (WAND); Brazil (Inmetro); Mexico (Registro Sanitario); Colombia (INVIMA); Costa Rica (Registro Sanitario).